Abdominal Aorta Balloon Occlusion Versus Standard Care in Placenta Accreta Spectrum Disorder: A Randomized Controlled Trial
Life · 02.07.2026 · 16 (7) · 1106
DOI: 10.3390/life16071106 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Life, online erschienen am 02.07.2026. Verfasst von Gauri Bapayeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Placenta accreta spectrum (PAS) is associated with substantial intraoperative hemorrhage. Abdominal aortic balloon occlusion (AABO) has been introduced to mitigate blood loss, though its benefit remains debated. This study, registered at ClinicalTrials.gov (NCT06721182), assessed maternal outcomes in women with PAS undergoing cesarean delivery managed either with abdominal aortic balloon occlusion or standard surgical care alone. The study (n = 65) and control (n = 75) groups were randomly assigned. Primary outcomes were estimated intraoperative blood loss and transfusion requirements. Secondary outcomes included operative time, hysterectomy, intensive care unit (ICU) admission, length of hospitalization, and complications. Management with AABO was associated with a reduction in estimated intraoperative blood loss (1433.08 ± 1064.97 mL for AABO vs. 2213.33 ± 1574.06 mL in control) and lower transfusion requirements (687.48 ± 979.23 mL for AABO vs. 1161.84 ± 1140.33 mL in control). The incidence of hysterectomy was lower among patients managed with AABO; while this difference was not statistically significant, it was regarded as clinically important. No significant differences were observed in ICU admission rates, duration of hospital stay, or operative time. Procedure-related complications were observed. AABO was associated with lower perioperative blood loss and transfusion requirements, without an increase in overall complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
- Department of Surgery, School of Medicine, Nazarbayev University, Astana Z05P3Y4, Kazakhstan.
- Clinical Academic Department of Radiology and Nuclear Medicine, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
- Clinical Academic Department of Anaesthesiology and Intensive Care, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
- Clinical Academic Department of Pathology, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
ORCID-Profile: Meruyert Abdukassimova, Nazira Kadroldinova, Viktor Zemlyanskiy, Kuanysh Balgynbayev, Gulzhanat Aimagambetova, Milan Terzic
Förderung
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Bapayeva, G., Abdukassimova, M., Kadroldinova, N., Kassymbek, K., Togyzbayeva, K., Saidildina, L., Zemlyanskiy, V., Balgynbayev, K., Usseyeva, M., Aimagambetova, G., & Terzic, M. (2026). Abdominal Aorta Balloon Occlusion Versus Standard Care in Placenta Accreta Spectrum Disorder: A Randomized Controlled Trial. Life, 16(7), 1106. https://doi.org/10.3390/life16071106
Vancouver
Bapayeva G, Abdukassimova M, Kadroldinova N, Kassymbek K, Togyzbayeva K, Saidildina L, et al. Abdominal Aorta Balloon Occlusion Versus Standard Care in Placenta Accreta Spectrum Disorder: A Randomized Controlled Trial. Life. 2026;16(7):1106. doi:10.3390/life16071106
BibTeX
@article{Bapayeva2026,
author = {Bapayeva, Gauri and Abdukassimova, Meruyert and Kadroldinova, Nazira and Kassymbek, Kuat and Togyzbayeva, Karlygash and Saidildina, Lyazzat and Zemlyanskiy, Viktor and Balgynbayev, Kuanysh and Usseyeva, Mariya and Aimagambetova, Gulzhanat and Terzic, Milan},
title = {Abdominal Aorta Balloon Occlusion Versus Standard Care in Placenta Accreta Spectrum Disorder: A Randomized Controlled Trial},
journal = {Life},
year = {2026},
volume = {16},
number = {7},
pages = {1106},
doi = {10.3390/life16071106}
}
EUVIMED